S Michael Weiss

Affiliations

  • Director at Checkpoint Therapeutics Inc. (CKPT), 2025-05-30
  • Ceo at Tg Therapeutics Inc. (TGTX), 2025-01-30
  • Executive Vice Chairman at Fortress Biotech Inc. (FBIO), 2025-01-03
  • Director at Mustang Bio Inc. (MBIO), 2023-07-07
  • Director at Avenue Therapeutics Inc. (ATXI), 2018-08-09
  • Large Shareholder, Director at National Holdings Corp (NHLD), 2016-09-22
  • Co-Chairman Of The Board at Cb Pharma Acquisition Corp. (CNLM), 2014-12-12
  • Large Shareholder at Keryx Biopharmaceuticals Inc (KERX), 2010-05-12
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FBIO $1.70 147,058 $249,998.60 1,130,520 2023-11-14 Filing
TGTX $10.13 100,000 $1,013,000.00 12,073,021 2023-08-11 Filing
FBIO $0.84 1,197,604 $999,999.34 14,752,034 2023-02-10 Filing
TGTX $7.04 50,000 $351,750.00 12,878,185 2019-06-26 Filing
CNDO $1.61 1,000,000 $1,610,000.00 6,938,038 2014-11-06 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TGTX $18.31 30,671 $561,586.01 10,988,021 2022-01-05 Filing
TGTX $19.20 37,549 $720,940.80 13,455,697 2022-01-04 Filing
TGTX $16.44 210,618 $3,462,559.92 8,120,773 2014-12-16 Filing
KERX $5.94 47,719 $283,450.86 1,320,418 2010-05-10 Filing
KERX $6.09 50,000 $304,500.00 1,368,137 2010-05-09 Filing